Robust survivorship care is important because cancer patients have a unique set of medical needs,” said Melissa Erickson, MD.

Clinical trial sites often open and close rapidly, with 60% ceasing operations within the first year, impacting patient ...

Immunovant remains a high-risk, high-reward play, hinging on the success of its next-gen candidate IMVT-1402. Click to read my latest analysis of IMVT stock.

A new tool at its Tisch Cancer Center helps improve accuracy, efficiency and patient access by streamlining information from the Epic EHR to clinical trial platforms.

Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial ...

As the world becomes more digital, clinical research is evolving. One major change is the rise of decentralized clinical ...

Real-world evidence helps pharmaceutical companies and payers communicate more effectively. In this Q&A, Cate Lockhart, PharmD, PhD, chief science officer of the Academy of Managed Care Pharmacy (AMCP ...

Canada has no accreditation or inspection system for research ethics boards for clinical drug trials, and no oversight ...

Today, the American Lung Association Research Institute announced it has invested $22 million in new research grants, clinical research and strategic partnerships to advance the understanding, ...

Amid rapid advances in oncology, barriers such as treatment costs, health inequities, and clinician burnout remain critical challenges, as highlighted by experts at a regional Institute for ...

Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) le ...